ClinicalTrials.gg

BioMarin Pharmaceutical clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 172 studies whose lead sponsor is BioMarin Pharmaceutical or one of 4 companies grouped under it. 18 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 13, 2026.

Our grouping of 5 registry names, not the registry’s. See them and correct one ↓

Compare BioMarin Pharmaceutical with Kyowa Kirin and Otsuka →

Pipeline: 8 programs

Each counted once: 8 with a study BioMarin Pharmaceutical leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 4 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of BioMarin Pharmaceutical’s own registered studies; BioMarin Pharmaceutical’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs BioMarin Pharmaceutical’s studies test, most open studies first — 19 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 9 more

Coming up

5 of BioMarin Pharmaceutical’s studies under way reach primary completion within a year, 3 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. F
  5. 1M
  6. 1A
  7. M
  8. J
  9. 1J
  10. A
  11. 1S
  12. O
  13. N

Add all 5 to your calendar (.ics) → With an account.

All 172 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1810%Recruiting 15 · Enrolling by invitation 3
  • Under way, not recruiting138%
  • Completed9958%
  • Stopped early3420%Terminated 32 · Withdrawn 2
  • Status unknown or other85%Approved for marketing 3 · Available 3 · No longer available 1 · Status unknown 1

Phase

  • Phase 262
  • Phase 343
  • Phase 132
  • Phase 44

Where

  • United States137
  • United Kingdom78
  • Italy50
  • Germany48
  • Australia46
  • France45

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 1611
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 526

By the year each study started; 19 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to BioMarin Pharmaceutical.

  • BioMarin Pharmaceutical
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    112 studies
  • Amicus Therapeutics
    Acquired — became part of BioMarin Pharmaceutical, Apr 27, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    42 studies →
  • Inozyme Pharma
    Acquired — became part of BioMarin Pharmaceutical, Jul 1, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    12 studies →
  • Scioderm, Inc.
    Acquired — became part of BioMarin Pharmaceutical, Apr 27, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • Amicus Therapeutics France SAS
    Acquired — became part of BioMarin Pharmaceutical, Apr 27, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →

Focus areas

Conditions BioMarin Pharmaceutical leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 172. Browse all 172 →